HOME >> BIOLOGY >> NEWS
New compound effectively treats fungal infections

A new mechanism to attack hard-to-treat fungal infections has been revealed by scientists from the biotech company Anacor Pharmaceuticals Inc., California, and the European Molecular Biology Laboratory (EMBL) outstation in Grenoble, France. In the current issue of Science they describe how a new compound kills fungal pathogens by blocking an enzyme crucial for their protein synthesis.

The human body is home to many different kinds of fungi. While the majority normally do not harm us, some fungi can cause unpleasant infections of skin, nails or lungs.

We have discovered a new compound that has the potential to treat common chronic nail infections caused by fungi, says Dickon Alley, researcher at Anacor Pharmaceuticals. The compound, called AN2690, kills fungi by blocking their ability to make proteins.

AN2690 interferes with an enzyme called leucyl-tRNA synthetase, which is involved in translation, one of the last steps in the process of turning a genes DNA code into a protein. The process begins when the cell makes an RNA version of the genes code, called messenger RNA. Ribosomes, the cells protein synthesis machinery, then translate the messenger RNA into protein by stitching together the amino acids in the order specified by the message. This requires the help of molecules called tRNAs, which link the code of the messenger RNA to the correct amino acid.

Leucyl-tRNA synthetase is one of a group of enzymes called aminoacyl-tRNA synthetases that attach the correct amino acid to each tRNA. Some of these enzymes have two main functional parts, or active sites: a site that links the amino acid to the tRNA, and a separate editing site that proofreads this process and removes wrongly added amino acids.

To find out how exactly AN2690 blocks leucyl-tRNA synthetase Stephen Cusack, Head of EMBL Grenoble, and his team generated crystals of the enzyme bound to tRNA in the presence of AN2690. Examining them with the high-intensity X-ray source at th
'"/>

Contact: Anna-Lynn Wegener
wegener@embl.de
49-622-138-7452
European Molecular Biology Laboratory
22-Jun-2007


Page: 1 2

Related biology news :

1. A compound from olive-pomace oil gets 80 percent slowing down of HIV spread
2. Natural compound and exercise boost memory in mice
3. Lipoic acid explored as anti-aging compound
4. Pharmaceutical compounds found in nations fresh water
5. Chinese medicinal compound stops formation of cysts in polycystic kidney disease in lab
6. EPA selects Phylonix to screen compound library in zebrafish
7. Anti-wrinkle compound causes pathological reaction in skin cells
8. Marine moss reveals clues to anticancer compound
9. New compound prevents alcoholic behavior, relapse in animals by blocking stress response
10. Light-activated compound silences nerves, may one day help epileptics
11. New compound isolated from Madagascan plant shows activity against malaria

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/17/2018)... ... August 16, 2018 , ... ... an established epigenetics service provider based in Gent, Belgium. NXT-Dx provides a ... methylation assays using pyrosequencing or Next-Generation Sequencing and Illumina’s Infinium Methylation EPIC ...
(Date:8/17/2018)... ... ... Today, the FSH Society , the world’s largest research-focused patient advocacy ... its 3rd annual Walk & Roll to Cure FSHD in Castle Rock. ... public awareness and is raising funds to support the Society’s work. , The FSH ...
(Date:8/15/2018)... ... 15, 2018 , ... Exalto Bearings UK , the manufacturer of high ... its ISO quality management certification to BS EN ISO 9001:2015. This ISO standard is ... the company’s ability to offer products and services of consistent high quality. , Over ...
Breaking Biology News(10 mins):
(Date:9/15/2018)... ... September 14, 2018 , ... Nationally recognized public accounting and consulting ... , Managing Partner of the Firm’s Nashville practice, on her appointment to Launch ... and was named Managing Partner of the Firm’s Nashville practice in December 2017 ...
(Date:9/12/2018)... ... 2018 , ... NDA Partners Chairman Carl Peck, MD, announced ... Regulatory Affairs and Quality Systems at WellDoc, Inc., has joined the firm as ... Systems at WellDoc, Inc., she conducted quality control and supplier audits, led inspections ...
(Date:9/7/2018)... (PRWEB) , ... September 06, 2018 , ... Akadeum Life ... has spent his career as an executive and leader of numerous biotech companies. ... cell therapy and biologics company acquired by Thompson Street Capital in St. Louis, MO. ...
(Date:8/29/2018)... , ... August 28, 2018 , ... Cognition Corporation ... full lineup of talks for NAVIGATE2018 . , Ryan Ward, Director of ... Cognition’s annual user conference. An experienced engineer and manager with Zimmer Biomet for almost ...
Breaking Biology Technology:
Cached News: